These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

441 related articles for article (PubMed ID: 15219188)

  • 1. Antiphospholipid antibodies: do we still need to perform anticardiolipin ELISA assays?
    de Moerloose P; Reber G
    J Thromb Haemost; 2004 Jul; 2(7):1071-3. PubMed ID: 15219188
    [No Abstract]   [Full Text] [Related]  

  • 2. Detection of 'antiphospholipid' antibodies: a single chromogenic assay of thrombin generation sensitively detects lupus anticoagulants, anticardiolipin antibodies, plus antibodies binding beta(2)-glycoprotein I and prothrombin.
    Sheng Y; Hanly JG; Reddel SW; Kouts S; Guerin J; Koike T; Ichikawa K; Sturgess A; Krilis SA
    Clin Exp Immunol; 2001 Jun; 124(3):502-8. PubMed ID: 11472415
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Clinical significance of antiphospholipid antibodies].
    Atsumi T; Koike T
    Rinsho Byori; 1998 Apr; 46(4):297-302. PubMed ID: 9594618
    [TBL] [Abstract][Full Text] [Related]  

  • 4. APhL antibody ELISA as an alternative to anticardiolipin test for the diagnosis of antiphospholipid syndrome.
    Suh-Lailam BB; Cromar A; Davis KW; Tebo AE
    Int J Clin Exp Pathol; 2012; 5(3):210-5. PubMed ID: 22558475
    [TBL] [Abstract][Full Text] [Related]  

  • 5. European attempts for the standardisation of the antiphospholipid antibodies.
    Tincani A; Filippini M; Scarsi M; Galli M; Meroni PL
    Lupus; 2009 Sep; 18(10):913-9. PubMed ID: 19671792
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Laboratory diagnosis of antiphospholipid syndrome].
    Darnige L
    Rev Med Interne; 2006 Apr; 27(4):296-301. PubMed ID: 16236386
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An adapted ELISA method for differentiating pathogenic from nonpathogenic aPL by a beta 2 glycoprotein I dependency anticardiolipin assay.
    Levy RA; de Meis E; Pierangeli S
    Thromb Res; 2004; 114(5-6):573-7. PubMed ID: 15507293
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diagnosis of antiphospholipid antibodies.
    Petri M
    Rheum Dis Clin North Am; 1994 May; 20(2):443-69. PubMed ID: 8016420
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Laboratory evaluation of the antiphospholipid syndrome.
    Abo SM; DeBari VA
    Ann Clin Lab Sci; 2007; 37(1):3-14. PubMed ID: 17311864
    [TBL] [Abstract][Full Text] [Related]  

  • 10. More on: criteria to define the antiphospholipid syndrome.
    Tripodi A
    J Thromb Haemost; 2008 Jun; 6(6):1049-50. PubMed ID: 18363821
    [No Abstract]   [Full Text] [Related]  

  • 11. Laboratory criteria for antiphospholipid syndrome: communication from the SSC of the ISTH.
    Devreese KMJ; Ortel TL; Pengo V; de Laat B;
    J Thromb Haemost; 2018 Apr; 16(4):809-813. PubMed ID: 29532986
    [No Abstract]   [Full Text] [Related]  

  • 12. Antiphospholipid antibodies may be a new prognostic parameter in aggressive non-Hodgkin's lymphoma.
    Bairey O; Blickstein D; Monselise Y; Lahav J; Stark P; Prokocimer M; Nativ HM; Kirgner I; Pazgal I; Shaklai M
    Eur J Haematol; 2006 May; 76(5):384-91. PubMed ID: 16466368
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Anti-phospholipid antibody (aPL)].
    Gotoh M; Matsuda J
    Nihon Rinsho; 2004 Dec; 62 Suppl 12():687-90. PubMed ID: 15658424
    [No Abstract]   [Full Text] [Related]  

  • 14. Invitation to a debate on the serological criteria that define the antiphospholipid syndrome.
    Galli M; Reber G; de Moerloose P; de Groot PG
    J Thromb Haemost; 2008 Feb; 6(2):399-401. PubMed ID: 18067604
    [No Abstract]   [Full Text] [Related]  

  • 15. A consensus approach to the formulation of guidelines for laboratory testing and reporting of antiphospholipid antibody assays.
    Wong RC; Favaloro EJ
    Semin Thromb Hemost; 2008 Jun; 34(4):361-72. PubMed ID: 18814070
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antiphospholipid antibodies and platelets.
    De Jong A; Ziboh V; Robbins D
    Curr Rheumatol Rep; 2000 Jun; 2(3):238-45. PubMed ID: 11123065
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical consequences of antiphospholipid antibodies.
    Derksen RH; de Groot PG
    Neth J Med; 2004 Sep; 62(8):273-8. PubMed ID: 15588067
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Antiphospholipid syndrome diagnosis: an update].
    Visseaux B; Masliah-Planchon J; Fischer AM; Darnige L
    Ann Biol Clin (Paris); 2011; 69(4):411-8. PubMed ID: 21896405
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antibodies to phosphatidylserine/prothrombin complex in suspected antiphospholipid syndrome in the absence of antibodies to cardiolipin or Beta-2-glycoprotein I.
    Sanfelippo MJ; Joshi A; Schwartz S; Meister JA; Goldberg JW
    Lupus; 2013 Nov; 22(13):1349-52. PubMed ID: 23989738
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of high thrombotic risk triple-positive antiphospholipid syndrome patients is dependent on anti-cardiolipin and anti-β2glycoprotein I antibody detection assays.
    Chayoua W; Kelchtermans H; Moore GW; Musiał J; Wahl D; de Laat B; Devreese KMJ
    J Thromb Haemost; 2018 Oct; 16(10):2016-2023. PubMed ID: 30079628
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.